{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-005805","form_type":"8-K","ticker":"CELZ","cik":"0001187953","company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","filed_at":"2026-09-25T21:00:47+00:00","discovered_at":"2026-09-25T21:02:03.281331+00:00","generated_at":"2026-10-12T13:26:30.726440+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CELZ buys 4M BioDefense shares for $200K cash plus 1M CELZ shares, lifting stake to 80%","bullets":["Creative Medical Technology Holdings acquired 4,000,000 BioDefense, Inc. shares from Creative Acquisition Corp. for $200,000 cash plus 1,000,000 CELZ common shares; closing Sept. 24, 2026.","After the deal CELZ holds 16,000,000 BioDefense shares (80% of outstanding), with seller CAC retaining 4,000,000 shares (20%).","CAC is controlled by CELZ President/CEO Timothy Warbington, who is Chairman/CEO of CAC and indirectly owns all of its stock, making this a related-party transaction.","The 1,000,000 CELZ shares were issued in a private placement under Section 4(a)(2) of the Securities Act and are unregistered, with transfer restrictions noted in the agreement.","Agreement executed by Warbington for CAC and CFO Donald Dickerson for CELZ; governed by Nevada law, with a Stock Power transferring the 4M BioDefense shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-005805","json":"https://secwatch.observer/filing/0001477932-26-005805.json","markdown":"https://secwatch.observer/filing/0001477932-26-005805.md","text":"https://secwatch.observer/filing/0001477932-26-005805.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1187953/000147793226005805/0001477932-26-005805-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1187953/000147793226005805/celz_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T13:26:30.726440+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}